Drugs / BMS-844421
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01082562 | Apr → Jul 2010 | atherosclerosis, hyperlipidemia | Bristol-Myers Squibb | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-844421 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01082562 ↗ |
| Route | Intravenous | “Ready-to-use stock solution for SC and IV” NCT01082562 ↗ |
| Route | Subcutaneous | “Ready-to-use stock solution for SC and IV” NCT01082562 ↗ |